APC UPS

Source: https://wiki.archlinux.org/title/APC_UPS

The APC UPS can communicate with the Linux system through either a RS-232 or USB serial connection.

Debian packages:

apcupsd – APC UPS Power Management (daemon)
apcupsd-cgi – APC UPS Power Management (web interface)

Posted in GNU/Linux | Tagged , , | Leave a comment

Many riders think the problem is speed…it is not.

Does speed on a motorcycle kill?
Speed differential is the bigger problem.

Posted in Motorcycle | Tagged , | Leave a comment

Yes, you are all Wrong.

Posted in Bigger reality | Tagged | Leave a comment

Russian Sanctions On Europe

Gonzalo Lira

Posted in Bigger reality | Leave a comment

Review of the best “de-googled” mobile phone for PRIVACY and security

https://www.brighteon.com/b114f80f-aa5b-4ac8-a028-e59671cafb70

Posted in Science and technologies | Leave a comment

Broken love that destroys another human.

If a man or a woman expect for you to worship or devotion from you, end the relationship as quickly as you can. Such people are blinded by broken love.

The feeling of love and pleasure, intimacy between man and woman are so addictive, electrifying during romantic relationship. Both parties promise each other and make life-changing plans together such as marriage. Everything would be fine, tomorrow would be joyful, lovely, and excitement.

But one party’s behavior starts to change suddenly. The frequency of communication, level of enthusiasm are reduced. One day the communication is terminated and the other party would have lived in darkness for months or even years.

Being innocent or having invested so many time and energy to the person, the other party delays the decision of ending relationship and move on.

Going back to lonely life as a single is scary and the fading hope of getting back the loved one still exists. Even a man like me who thinks crying is luxury emotion, ending relationship with a girlfriend is reluctant and painful experience.

Being honest, compatible each other, and share similar interests and lifestyle do not guarantee long-term relationship if the partner is believer of broken love and selfish.

Broken woman or man think their partner should tolerate or love them whatever action they do because that’s their broken version of love. Demanding explanation about lie or disappearance triggers mistrust and hate. So they begin to things behind the back.

Silly excuses and formal conversation without substance or care fill the space between them.

To me, love or happiness are just concept human creates in mind. These are illusive and subjective. Life is much more than love or happiness. So many people believe in the purpose of life should be happiness. So many single women think they should find the man who gives love to them.

I think beautiful, strong relationship between a couple should be built on real life with least expectation. If two parties care each other and try to understand whenever there is miscommunication or mistake, they will have good life together for years.

A photo is better than thousands of words.

A genuine action is better than hundreds of photos or many hours of video chat.

Posted in Bigger reality | Tagged , , | Leave a comment

Army veteran wins $50 million lawsuit against 3M over defective combat earplugs that caused hearing damage

Source: https://citizens.news/605994.html

(Natural News) A veteran of the United States Army won a $50 million lawsuit against 3M over defective earplugs that caused hearing damage.

Luke Vilsmeyer, 42, of Indiana, served in the Army from 1999 to 2020, first as a howitzer gunner and later as a Green Beret. His initial position in the army exposed him to the loudest and most potentially harmful noise levels possible.

According to Vilsmeyer’s lawsuit, he used 3M’s Combat Arms Earplugs Version 2 for most of his time in the army. He believed the products should have protected him from the worst possible hearing damage he could get. But the earplugs did not work, and he later suffered permanent hearing loss and severe tinnitus. (Related: Routine MRI ruins a woman’s life by making her so sensitive to sound that she can’t go out in public.)

Following a 10-day trial, a jury in Pensacola, Florida decided that Vilsmeyer had adequately proved his claims that his hearing loss was caused by defects in 3M’s earplugs. He was awarded $50 million. This was the second-largest amount won in litigation against 3M and was made up entirely of compensatory damages.

Another veteran won lawsuit against 3M for hearing damage
Vilsmeyer is not the only veteran to win a lawsuit against 3M. In Tallahassee, a jury awarded $8 million in compensatory damages to Army National Guard veteran Steve Wilkerson, who said using the earplugs did not protect him from developing tinnitus and hearing loss.

Wilkerson used the Army-issued 3M earplugs for several years during his time in the National Guard, which included a combat rotation in Afghanistan.

Brighteon.TV
In its defense, 3M suggested that Wilkerson’s alleged hearing loss and tinnitus were pre-existing and the result of him being part of a band playing guitar for many years before his time in the National Guard.

This counter-argument was not enough for the jury, who found that Wilkerson had sufficiently proven that his hearing damage was caused by the deficiencies in 3M’s product.

Over 280,000 veterans suing 3M for defective earplugs
Vilsmeyer and Wilkerson are among the more than 280,000 former and active military personnel who have sued 3M, claiming the company’s combat earplugs are defective and have damaged their hearing. This is the largest federal mass tort litigation in American history.

In a statement, the lead lawyers for the plaintiffs in this massive lawsuit noted that 3M had already lost six earlier trials regarding its defective earplugs. These six previous trials combined won plaintiffs more than $160 million. Two veterans alone were awarded $55 million each.

“It is clear 3M’s defenses – whether in the courts, to investors or the public – are unconvincing and without merit,” they wrote in a joint statement.

The plaintiffs allege 3M hid design flaws, fudged test results and failed to provide wearers with instructions for the proper use of the combat earplugs.

3M’s lawyers said in a statement that it was disappointed in the results of the Vilsmeyer and Wilkerson trials and will appeal. The company said the issues raised in its earlier appeals relating to evidentiary rulings and legal defenses applied to both cases.

“We remain confident in our case and will continue to defend our product and our record at trial and on appeal,” wrote the company’s lawyers.

Thirteen trials have already been concluded against 3M’s combat earplugs. Three more bellwether plaintiffs are expected to go to trial in the next two months, including the case of Denise Kelley, which began on Monday, March 28.

This trial is expected to last two weeks. According to Ronald V. Miller, Jr., writing for Lawsuit Information Center Blog, if the jury sides with Kelley, it could be “the death knell for 3M.”

Watch this video and learn about natural treatments for hearing loss and tinnitus.

Posted in Health | Tagged , , , | Leave a comment

Pfizer BNT162b2 Covid-19 Vaccine, LIST OF ADVERSE EVENTS OF SPECIAL INTEREST (1200+)

APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST

1p36 deletion syndrome; 2-Hydroxyglutaric aciduria; 5’nucleotidase increased; Acoustic neuritis; Acquired C1 inhibitor deficiency; Acquired epidermolysis bullosa;
Acquired epileptic aphasia; Acute cutaneous lupus erythematosus;
Acute disseminated encephalomyelitis; Acute encephalitis with refractory, repetitive partial seizures; Acute febrile neutrophilic dermatosis; Acute flaccid myelitis; Acute haemorrhagic leukoencephalitis; Acute haemorrhagic oedema of infancy; Acute kidney injury; Acute macular outer retinopathy; Acute motor axonal neuropathy; Acute motor-sensory axonal neuropathy; Acute myocardial infarction; Acute respiratory distress syndrome; Acute respiratory failure; Addison’s disease; Administration site thrombosis; Administration site vasculitis; Adrenal thrombosis; Adverse event following immunisation; Ageusia; Agranulocytosis; Air embolism; Alanine aminotransferase abnormal; Alanine aminotransferase increased; Alcoholic seizure; Allergic bronchopulmonary mycosis; Allergic oedema; Alloimmune hepatitis; Alopecia areata; Alpers disease; Alveolar proteinosis; Ammonia abnormal; Ammonia increased; Amniotic cavity infection; Amygdalohippocampectomy; Amyloid arthropathy; Amyloidosis; Amyloidosis senile; Anaphylactic reaction; Anaphylactic
shock; Anaphylactic transfusion reaction; Anaphylactoid reaction; Anaphylactoid
shock; Anaphylactoid syndrome of pregnancy; Angioedema; Angiopathic
neuropathy; Ankylosing spondylitis; Anosmia; Antiacetylcholine receptor antibody
positive; Anti-actin antibody positive; Anti-aquaporin-4 antibody positive; Anti-basal ganglia antibody positive; Anti-cyclic citrullinated peptide antibody positive; Anti-epithelial antibody positive; Anti-erythrocyte antibody positive; Anti-exosome complex antibody positive; AntiGAD antibody negative; Anti-GAD antibody positive; Anti-ganglioside antibody positive; Antigliadin antibody positive; Anti-glomerular basement membrane antibody positive; Anti-glomerular basement membrane disease; Anti-glycyl-tRNA synthetase antibody positive; Anti-HLA antibody test positive; Anti-IA2 antibody positive; Anti-insulin antibody
increased; Anti-insulin antibody positive; Anti-insulin receptor antibody increased; Antiinsulin receptor antibody positive; Anti-interferon antibody negative; Anti-interferon antibody positive; Anti-islet cell antibody positive; Antimitochondrial antibody positive; Anti-muscle
specific kinase antibody positive; Anti-myelin-associated glycoprotein antibodies
positive; Anti-myelin-associated glycoprotein associated polyneuropathy; Antimyocardial antibody positive; Anti-neuronal antibody positive; Antineutrophil cytoplasmic antibody increased; Antineutrophil cytoplasmic antibody positive; Anti-neutrophil cytoplasmic antibody positive vasculitis; Anti-NMDA antibody positive; Antinuclear antibody increased; Antinuclear antibody positive; Antiphospholipid antibodies positive; Antiphospholipid syndrome; Anti-platelet antibody positive; Anti-prothrombin antibody positive; Antiribosomal P antibody positive; Anti-RNA polymerase III antibody positive; Anti-saccharomyces cerevisiae antibody test positive; Anti-sperm antibody positive; Anti-SRP antibody positive; Antisynthetase syndrome; Anti-thyroid antibody
positive; Anti-transglutaminase antibody increased; Anti-VGCC antibody positive; AntiVGKC antibody positive; Anti-vimentin antibody positive; Antiviral prophylaxis; Antiviral treatment; Anti-zinc transporter 8 antibody positive; Aortic embolus; Aortic thrombosis; Aortitis; Aplasia pure red cell; Aplastic anaemia; Application site thrombosis; Application site vasculitis; Arrhythmia; Arterial bypass occlusion; Arterial bypass thrombosis; Arterial thrombosis; Arteriovenous fistula thrombosis; Arteriovenous graft site stenosis; Arteriovenous graft thrombosis; Arteritis; Arteritis

Page 30
090177e196ea1800\Approved\Approved On: 30-A
pr-2021 09:26 (GMT)
FDA-CBER-2021-5683-0000083
BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL

coronary; Arthralgia; Arthritis; Arthritis enteropathic; Ascites; Aseptic cavernous sinus
thrombosis; Aspartate aminotransferase abnormal; Aspartate aminotransferase
increased; Aspartate-glutamate-transporter deficiency; AST to platelet ratio index
increased; AST/ALT ratio abnormal; Asthma; Asymptomatic COVID19; Ataxia; Atheroembolism; Atonic seizures; Atrial thrombosis; Atrophic thyroiditis; Atypical benign partial epilepsy; Atypical pneumonia; Aura; Autoantibody positive; Autoimmune anaemia; Autoimmune aplastic anaemia; Autoimmune arthritis; Autoimmune blistering disease; Autoimmune cholangitis; Autoimmune colitis; Autoimmune demyelinating disease; Autoimmune dermatitis; Autoimmune disorder; Autoimmune encephalopathy; Autoimmune endocrine disorder; Autoimmune enteropathy; Autoimmune eye
disorder; Autoimmune haemolytic anaemia; Autoimmune heparin-induced
thrombocytopenia; Autoimmune hepatitis; Autoimmune hyperlipidaemia; Autoimmune hypothyroidism; Autoimmune inner ear disease; Autoimmune lung disease; Autoimmune lymphoproliferative syndrome; Autoimmune myocarditis; Autoimmune myositis; Autoimmune
nephritis; Autoimmune neuropathy; Autoimmune neutropenia; Autoimmune
pancreatitis; Autoimmune pancytopenia; Autoimmune pericarditis; Autoimmune
retinopathy; Autoimmune thyroid disorder; Autoimmune thyroiditis; Autoimmune
uveitis; Autoinflammation with infantile enterocolitis; Autoinflammatory disease; Automatism epileptic; Autonomic nervous system imbalance; Autonomic seizure; Axial spondyloarthritis; Axillary vein thrombosis; Axonal and demyelinating
polyneuropathy; Axonal neuropathy; Bacterascites; Baltic myoclonic epilepsy; Band
sensation; Basedow’s disease; Basilar artery thrombosis; Basophilopenia; B-cell
aplasia; Behcet’s syndrome; Benign ethnic neutropenia; Benign familial neonatal
convulsions; Benign familial pemphigus; Benign rolandic epilepsy; Beta-2 glycoprotein antibody positive; Bickerstaff’s encephalitis; Bile output abnormal; Bile output decreased; Biliary ascites; Bilirubin conjugated abnormal; Bilirubin conjugated increased; Bilirubin urine present; Biopsy liver abnormal; Biotinidase deficiency; Birdshot chorioretinopathy; Blood alkaline phosphatase abnormal; Blood alkaline phosphatase increased; Blood bilirubin abnormal; Blood bilirubin increased; Blood bilirubin unconjugated increased; Blood cholinesterase abnormal; Blood cholinesterase decreased; Blood pressure decreased; Blood pressure diastolic decreased; Blood pressure systolic decreased; Blue toe
syndrome; Brachiocephalic vein thrombosis; Brain stem embolism; Brain stem
thrombosis; Bromosulphthalein test abnormal; Bronchial oedema; Bronchitis; Bronchitis mycoplasmal; Bronchitis viral; Bronchopulmonary aspergillosis allergic; Bronchospasm; BuddChiari syndrome; Bulbar palsy; Butterfly rash; C1q nephropathy; Caesarean section; Calcium embolism; Capillaritis; Caplan’s syndrome; Cardiac amyloidosis; Cardiac arrest; Cardiac failure; Cardiac failure acute; Cardiac sarcoidosis; Cardiac ventricular thrombosis; Cardiogenic
shock; Cardiolipin antibody positive; Cardiopulmonary failure; Cardio-respiratory
arrest; Cardio-respiratory distress; Cardiovascular insufficiency; Carotid arterial
embolus; Carotid artery thrombosis; Cataplexy; Catheter site thrombosis; Catheter site vasculitis; Cavernous sinus thrombosis; CDKL5 deficiency disorder; CEC syndrome; Cement embolism; Central nervous system lupus; Central nervous system vasculitis; Cerebellar artery thrombosis; Cerebellar embolism; Cerebral amyloid angiopathy; Cerebral arteritis; Cerebral artery embolism; Cerebral artery thrombosis; Cerebral gas embolism; Cerebral microembolism; Cerebral septic infarct; Cerebral thrombosis; Cerebral venous sinus thrombosis; Cerebral venous thrombosis; Cerebrospinal thrombotic

Page 31
090177e196ea1800\Approved\Approved On: 30-A
pr-2021 09:26 (GMT)
FDA-CBER-2021-5683-0000084
BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL

tamponade; Cerebrovascular accident; Change in seizure presentation; Chest discomfort; ChildPugh-Turcotte score abnormal; Child-Pugh-Turcotte score
increased; Chillblains; Choking; Choking sensation; Cholangitis sclerosing; Chronic
autoimmune glomerulonephritis; Chronic cutaneous lupus erythematosus; Chronic fatigue syndrome; Chronic gastritis; Chronic inflammatory demyelinating
polyradiculoneuropathy; Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids; Chronic recurrent multifocal osteomyelitis; Chronic respiratory failure; Chronic spontaneous urticaria; Circulatory collapse; Circumoral oedema; Circumoral swelling; Clinically isolated syndrome; Clonic convulsion; Coeliac disease; Cogan’s syndrome; Cold agglutinins positive; Cold type haemolytic anaemia; Colitis; Colitis erosive; Colitis herpes; Colitis microscopic; Colitis ulcerative; Collagen disorder; Collagen-vascular disease; Complement factor abnormal; Complement factor C1
decreased; Complement factor C2 decreased; Complement factor C3 decreased; Complement factor C4 decreased; Complement factor decreased; Computerised tomogram liver abnormal; Concentric sclerosis; Congenital anomaly; Congenital bilateral perisylvian
syndrome; Congenital herpes simplex infection; Congenital myasthenic syndrome; Congenital varicella infection; Congestive hepatopathy; Convulsion in childhood; Convulsions local; Convulsive threshold lowered; Coombs positive haemolytic anaemia; Coronary artery disease; Coronary artery embolism; Coronary artery thrombosis; Coronary bypass thrombosis; Coronavirus infection; Coronavirus test; Coronavirus test negative; Coronavirus test positive; Corpus callosotomy; Cough; Cough variant asthma; COVID-19; COVID-19
immunisation; COVID-19 pneumonia; COVID-19 prophylaxis; COVID-19 treatment; Cranial nerve disorder; Cranial nerve palsies multiple; Cranial nerve paralysis; CREST syndrome; Crohn’s disease; Cryofibrinogenaemia; Cryoglobulinaemia; CSF oligoclonal band present; CSWS syndrome; Cutaneous amyloidosis; Cutaneous lupus erythematosus; Cutaneous sarcoidosis; Cutaneous vasculitis; Cyanosis; Cyclic neutropenia; Cystitis interstitial; Cytokine
release syndrome; Cytokine storm; De novo purine synthesis inhibitors associated acute inflammatory syndrome; Death neonatal; Deep vein thrombosis; Deep vein thrombosis postoperative; Deficiency of bile secretion; Deja vu; Demyelinating
polyneuropathy; Demyelination; Dermatitis; Dermatitis bullous; Dermatitis
herpetiformis; Dermatomyositis; Device embolisation; Device related thrombosis; Diabetes mellitus; Diabetic ketoacidosis; Diabetic mastopathy; Dialysis amyloidosis; Dialysis membrane reaction; Diastolic hypotension; Diffuse vasculitis; Digital pitting scar; Disseminated intravascular coagulation; Disseminated intravascular coagulation in newborn; Disseminated
neonatal herpes simplex; Disseminated varicella; Disseminated varicella zoster vaccine virus infection; Disseminated varicella zoster virus infection; DNA antibody positive; Double cortex syndrome; Double stranded DNA antibody positive; Dreamy state; Dressler’s syndrome; Drop attacks; Drug withdrawal convulsions; Dyspnoea; Early infantile epileptic encephalopathy with
burst-suppression; Eclampsia; Eczema herpeticum; Embolia cutis medicamentosa; Embolic cerebellar infarction; Embolic cerebral infarction; Embolic pneumonia; Embolic stroke; Embolism; Embolism arterial; Embolism venous; Encephalitis; Encephalitis allergic; Encephalitis autoimmune; Encephalitis brain stem; Encephalitis haemorrhagic; Encephalitis periaxialis diffusa; Encephalitis post
immunisation; Encephalomyelitis; Encephalopathy; Endocrine disorder; Endocrine
ophthalmopathy; Endotracheal intubation; Enteritis; Enteritis leukopenic; Enterobacter pneumonia; Enterocolitis; Enteropathic spondylitis; Eosinopenia; Eosinophilic

Page 32
090177e196ea1800\Approved\Approved On: 30-A
pr-2021 09:26 (GMT)
FDA-CBER-2021-5683-0000085
BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL

fasciitis; Eosinophilic granulomatosis with polyangiitis; Eosinophilic
oesophagitis; Epidermolysis; Epilepsy; Epilepsy surgery; Epilepsy with myoclonic-atonic seizures; Epileptic aura; Epileptic psychosis; Erythema; Erythema induratum; Erythema multiforme; Erythema nodosum; Evans syndrome; Exanthema subitum; Expanded disability status scale score decreased; Expanded disability status scale score increased; Exposure to communicable disease; Exposure to SARS-CoV-2; Eye oedema; Eye pruritus; Eye swelling; Eyelid oedema; Face oedema; Facial paralysis; Facial paresis; Faciobrachial dystonic seizure; Fat embolism; Febrile convulsion; Febrile infection-related epilepsy syndrome; Febrile neutropenia; Felty’s syndrome; Femoral artery embolism; Fibrillary glomerulonephritis; Fibromyalgia; Flushing; Foaming at mouth; Focal cortical resection; Focal
dyscognitive seizures; Foetal distress syndrome; Foetal placental thrombosis; Foetor hepaticus; Foreign body embolism; Frontal lobe epilepsy; Fulminant type 1 diabetes mellitus; Galactose elimination capacity test abnormal; Galactose elimination capacity test decreased; Gamma-glutamyltransferase abnormal; Gamma-glutamyltransferase increased; Gastritis herpes; Gastrointestinal amyloidosis; Gelastic seizure; Generalised onset non-motor seizure; Generalised tonic-clonic seizure; Genital herpes; Genital herpes
simplex; Genital herpes zoster; Giant cell arteritis; Glomerulonephritis; Glomerulonephritis membranoproliferative; Glomerulonephritis membranous; Glomerulonephritis rapidly progressive; Glossopharyngeal nerve paralysis; Glucose transporter type 1 deficiency syndrome; Glutamate dehydrogenase increased; Glycocholic acid increased; GM2
gangliosidosis; Goodpasture’s syndrome; Graft thrombosis; Granulocytopenia; Granulocytopenia neonatal; Granulomatosis with polyangiitis; Granulomatous dermatitis; Grey matter heterotopia; Guanase increased; GuillainBarre syndrome; Haemolytic anaemia; Haemophagocytic
lymphohistiocytosis; Haemorrhage; Haemorrhagic ascites; Haemorrhagic
disorder; Haemorrhagic pneumonia; Haemorrhagic varicella syndrome; Haemorrhagic vasculitis; Hantavirus pulmonary infection; Hashimoto’s
encephalopathy; Hashitoxicosis; Hemimegalencephaly; Henoch-Schonlein purpura; HenochSchonlein purpura nephritis; Hepaplastin abnormal; Hepaplastin decreased; Heparin-induced thrombocytopenia; Hepatic amyloidosis; Hepatic artery embolism; Hepatic artery flow decreased; Hepatic artery thrombosis; Hepatic enzyme abnormal; Hepatic enzyme decreased; Hepatic enzyme increased; Hepatic fibrosis marker abnormal; Hepatic fibrosis marker increased; Hepatic function abnormal; Hepatic hydrothorax; Hepatic hypertrophy; Hepatic hypoperfusion; Hepatic lymphocytic infiltration; Hepatic mass; Hepatic
pain; Hepatic sequestration; Hepatic vascular resistance increased; Hepatic vascular thrombosis; Hepatic vein embolism; Hepatic vein thrombosis; Hepatic venous pressure gradient abnormal; Hepatic venous pressure gradient increased; Hepatitis; Hepatobiliary scan abnormal; Hepatomegaly; Hepatosplenomegaly; Hereditary angioedema with C1 esterase inhibitor deficiency; Herpes dermatitis; Herpes gestationis; Herpes oesophagitis; Herpes
ophthalmic; Herpes pharyngitis; Herpes sepsis; Herpes simplex; Herpes simplex
cervicitis; Herpes simplex colitis; Herpes simplex encephalitis; Herpes simplex gastritis; Herpes simplex hepatitis; Herpes simplex meningitis; Herpes simplex meningoencephalitis; Herpes simplex meningomyelitis; Herpes simplex necrotising retinopathy; Herpes simplex oesophagitis; Herpes simplex otitis externa; Herpes simplex pharyngitis; Herpes simplex pneumonia; Herpes simplex reactivation; Herpes simplex sepsis; Herpes simplex viraemia; Herpes simplex virus conjunctivitis neonatal; Herpes simplex visceral; Herpes virus

Page 33
090177e196ea1800\Approved\Approved On: 30-A
pr-2021 09:26 (GMT)
FDA-CBER-2021-5683-0000086
BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL

infection; Herpes zoster; Herpes zoster cutaneous disseminated; Herpes zoster infection neurological; Herpes zoster meningitis; Herpes zoster meningoencephalitis; Herpes zoster meningomyelitis; Herpes zoster meningoradiculitis; Herpes zoster necrotising retinopathy; Herpes zoster oticus; Herpes zoster pharyngitis; Herpes zoster reactivation; Herpetic radiculopathy; Histone antibody positive; Hoigne’s syndrome; Human
herpesvirus 6 encephalitis; Human herpesvirus 6 infection; Human herpesvirus 6 infection reactivation; Human herpesvirus 7 infection; Human herpesvirus 8
infection; Hyperammonaemia; Hyperbilirubinaemia; Hypercholia; Hypergammaglobulinaemia benign monoclonal; Hyperglycaemic seizure; Hypersensitivity; Hypersensitivity vasculitis; Hyperthyroidism; Hypertransaminasaemia; Hyperventilation; Hypoalbuminaemia; Hypocalcaemic seizure; Hypogammaglobulinaemia; Hypoglossal nerve paralysis; Hypoglossal
nerve paresis; Hypoglycaemic seizure; Hyponatraemic seizure; Hypotension; Hypotensive crisis; Hypothenar hammer syndrome; Hypothyroidism; Hypoxia; Idiopathic CD4 lymphocytopenia; Idiopathic generalised epilepsy; Idiopathic interstitial pneumonia; Idiopathic neutropenia; Idiopathic pulmonary fibrosis; IgA nephropathy; IgM nephropathy; IIIrd nerve paralysis; IIIrd nerve paresis; Iliac artery embolism; Immune thrombocytopenia; Immunemediated adverse reaction; Immune-mediated cholangitis; Immune-mediated
cholestasis; Immune-mediated cytopenia; Immune-mediated encephalitis; Immune-mediated encephalopathy; Immune-mediated endocrinopathy; Immune-mediated enterocolitis; Immunemediated gastritis; Immune-mediated hepatic disorder; Immune-mediated hepatitis; Immunemediated hyperthyroidism; Immune-mediated hypothyroidism; Immune-mediated myocarditis; Immune-mediated myositis; Immune-mediated nephritis; Immune-mediated neuropathy; Immune-mediated pancreatitis; Immune-mediated pneumonitis; Immune-mediated renal disorder; Immune-mediated thyroiditis; Immune-mediated uveitis; Immunoglobulin G4
related disease; Immunoglobulins abnormal; Implant site thrombosis; Inclusion body myositis; Infantile genetic agranulocytosis; Infantile spasms; Infected vasculitis; Infective thrombosis; Inflammation; Inflammatory bowel disease; Infusion site thrombosis; Infusion site vasculitis; Injection site thrombosis; Injection site urticaria; Injection site vasculitis; Instillation site thrombosis; Insulin autoimmune syndrome; Interstitial granulomatous dermatitis; Interstitial lung disease; Intracardiac mass; Intracardiac thrombus; Intracranial pressure increased; Intrapericardial thrombosis; Intrinsic factor antibody abnormal; Intrinsic
factor antibody positive; IPEX syndrome; Irregular breathing; IRVAN syndrome; IVth nerve paralysis; IVth nerve paresis; JC polyomavirus test positive; JC virus CSF test positive; Jeavons syndrome; Jugular vein embolism; Jugular vein thrombosis; Juvenile idiopathic
arthritis; Juvenile myoclonic epilepsy; Juvenile polymyositis; Juvenile psoriatic
arthritis; Juvenile spondyloarthritis; Kaposi sarcoma inflammatory cytokine
syndrome; Kawasaki’s disease; Kayser-Fleischer ring; Keratoderma blenorrhagica; Ketosisprone diabetes mellitus; Kounis syndrome; Lafora’s myoclonic epilepsy; Lambl’s excrescences; Laryngeal dyspnoea; Laryngeal oedema; Laryngeal rheumatoid arthritis; Laryngospasm; Laryngotracheal oedema; Latent autoimmune diabetes in adults; LE cells present; Lemierre syndrome; Lennox-Gastaut syndrome; Leucine aminopeptidase increased; Leukoencephalomyelitis; Leukoencephalopathy; Leukopenia; Leukopenia neonatal; Lewis-Sumner syndrome; Lhermitte’s sign; Lichen planopilaris; Lichen planus; Lichen
sclerosus; Limbic encephalitis; Linear IgA disease; Lip oedema; Lip swelling; Liver function test abnormal; Liver function test decreased; Liver function test increased; Liver induration; Liver injury; Liver iron concentration abnormal; Liver iron concentration

Page 34
090177e196ea1800\Approved\Approved On: 30-A
pr-2021 09:26 (GMT)
FDA-CBER-2021-5683-0000087
BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL

increased; Liver opacity; Liver palpable; Liver sarcoidosis; Liver scan abnormal; Liver
tenderness; Low birth weight baby; Lower respiratory tract herpes infection; Lower respiratory tract infection; Lower respiratory tract infection viral; Lung abscess; Lupoid hepatic cirrhosis; Lupus cystitis; Lupus encephalitis; Lupus endocarditis; Lupus enteritis; Lupus hepatitis; Lupus myocarditis; Lupus myositis; Lupus nephritis; Lupus pancreatitis; Lupus pleurisy; Lupus pneumonitis; Lupus vasculitis; Lupus-like syndrome; Lymphocytic hypophysitis; Lymphocytopenia neonatal; Lymphopenia; MAGIC syndrome; Magnetic resonance imaging liver abnormal; Magnetic resonance proton density fat fraction measurement; Mahler sign; Manufacturing laboratory analytical testing issue; Manufacturing
materials issue; Manufacturing production issue; Marburg’s variant multiple
sclerosis; Marchiafava-Bignami disease; Marine Lenhart syndrome; Mastocytic
enterocolitis; Maternal exposure during pregnancy; Medical device site thrombosis; Medical device site vasculitis; MELAS syndrome; Meningitis; Meningitis aseptic; Meningitis herpes; Meningoencephalitis herpes simplex neonatal; Meningoencephalitis herpetic; Meningomyelitis herpes; MERS-CoV test; MERS-CoV test negative; MERS-CoV test positive; Mesangioproliferative glomerulonephritis; Mesenteric artery embolism; Mesenteric
artery thrombosis; Mesenteric vein thrombosis; Metapneumovirus infection; Metastatic cutaneous Crohn’s disease; Metastatic pulmonary
embolism; Microangiopathy; Microembolism; Microscopic polyangiitis; Middle East
respiratory syndrome; Migraine-triggered seizure; Miliary pneumonia; Miller Fisher
syndrome; Mitochondrial aspartate aminotransferase increased; Mixed connective tissue disease; Model for end stage liver disease score abnormal; Model for end stage liver disease score increased; Molar ratio of total branched-chain amino acid to tyrosine; Molybdenum cofactor deficiency; Monocytopenia; Mononeuritis; Mononeuropathy multiplex; Morphoea; Morvan syndrome; Mouth swelling; Moyamoya disease; Multifocal motor neuropathy; Multiple organ dysfunction syndrome; Multiple sclerosis; Multiple sclerosis relapse; Multiple sclerosis relapse prophylaxis; Multiple subpial transection; Multisystem
inflammatory syndrome in children; Muscular sarcoidosis; Myasthenia gravis; Myasthenia gravis crisis; Myasthenia gravis neonatal; Myasthenic syndrome; Myelitis; Myelitis transverse; Myocardial infarction; Myocarditis; Myocarditis post infection; Myoclonic epilepsy; Myoclonic epilepsy and ragged-red fibres; Myokymia; Myositis; Narcolepsy; Nasal herpes; Nasal obstruction; Necrotising herpetic retinopathy; Neonatal Crohn’s disease; Neonatal epileptic seizure; Neonatal lupus erythematosus; Neonatal mucocutaneous herpes simplex; Neonatal pneumonia; Neonatal seizure; Nephritis; Nephrogenic systemic
fibrosis; Neuralgic amyotrophy; Neuritis; Neuritis cranial; Neuromyelitis optica pseudo relapse; Neuromyelitis optica spectrum disorder; Neuromyotonia; Neuronal
neuropathy; Neuropathy peripheral; Neuropathy, ataxia, retinitis pigmentosa
syndrome; Neuropsychiatric lupus; Neurosarcoidosis; Neutropenia; Neutropenia
neonatal; Neutropenic colitis; Neutropenic infection; Neutropenic sepsis; Nodular rash; Nodular vasculitis; Noninfectious myelitis; Noninfective encephalitis; Noninfective encephalomyelitis; Noninfective oophoritis; Obstetrical pulmonary embolism; Occupational exposure to communicable disease; Occupational exposure to SARS-CoV-2; Ocular hyperaemia; Ocular myasthenia; Ocular pemphigoid; Ocular sarcoidosis; Ocular vasculitis; Oculofacial paralysis; Oedema; Oedema blister; Oedema due to hepatic disease; Oedema mouth; Oesophageal achalasia; Ophthalmic artery thrombosis; Ophthalmic herpes simplex; Ophthalmic herpes zoster; Ophthalmic vein thrombosis; Optic neuritis; Optic

Page 35
090177e196ea1800\Approved\Approved On: 30-A
pr-2021 09:26 (GMT)
FDA-CBER-2021-5683-0000088
BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL

neuropathy; Optic perineuritis; Oral herpes; Oral lichen planus; Oropharyngeal
oedema; Oropharyngeal spasm; Oropharyngeal swelling; Osmotic demyelination
syndrome; Ovarian vein thrombosis; Overlap syndrome; Paediatric autoimmune
neuropsychiatric disorders associated with streptococcal infection; Paget-Schroetter syndrome; Palindromic rheumatism; Palisaded neutrophilic granulomatous dermatitis; Palmoplantar keratoderma; Palpable purpura; Pancreatitis; Panencephalitis; Papillophlebitis; Paracancerous pneumonia; Paradoxical
embolism; Parainfluenzae viral laryngotracheobronchitis; Paraneoplastic
dermatomyositis; Paraneoplastic pemphigus; Paraneoplastic thrombosis; Paresis cranial nerve; Parietal cell antibody positive; Paroxysmal nocturnal haemoglobinuria; Partial seizures; Partial seizures with secondary generalisation; Patient isolation; Pelvic venous thrombosis; Pemphigoid; Pemphigus; Penile vein thrombosis; Pericarditis; Pericarditis lupus; Perihepatic discomfort; Periorbital oedema; Periorbital swelling; Peripheral artery thrombosis; Peripheral embolism; Peripheral ischaemia; Peripheral vein thrombus
extension; Periportal oedema; Peritoneal fluid protein abnormal; Peritoneal fluid protein decreased; Peritoneal fluid protein increased; Peritonitis lupus; Pernicious anaemia; Petit mal epilepsy; Pharyngeal oedema; Pharyngeal swelling; Pityriasis lichenoides et varioliformis acuta; Placenta praevia; Pleuroparenchymal fibroelastosis; Pneumobilia; Pneumonia; Pneumonia adenoviral; Pneumonia cytomegaloviral; Pneumonia herpes viral; Pneumonia influenzal; Pneumonia measles; Pneumonia mycoplasmal; Pneumonia necrotising; Pneumonia
parainfluenzae viral; Pneumonia respiratory syncytial viral; Pneumonia viral; POEMS
syndrome; Polyarteritis nodosa; Polyarthritis; Polychondritis; Polyglandular autoimmune syndrome type I; Polyglandular autoimmune syndrome type II; Polyglandular autoimmune syndrome type III; Polyglandular disorder; Polymicrogyria; Polymyalgia rheumatica; Polymyositis; Polyneuropathy; Polyneuropathy idiopathic progressive; Portal pyaemia; Portal vein embolism; Portal vein flow decreased; Portal vein pressure increased; Portal vein thrombosis; Portosplenomesenteric venous thrombosis; Post procedural hypotension; Post procedural pneumonia; Post procedural pulmonary embolism; Post stroke
epilepsy; Post stroke seizure; Post thrombotic retinopathy; Post thrombotic syndrome; Post viral fatigue syndrome; Postictal headache; Postictal paralysis; Postictal psychosis; Postictal state; Postoperative respiratory distress; Postoperative respiratory failure; Postoperative thrombosis; Postpartum thrombosis; Postpartum venous thrombosis; Postpericardiotomy syndrome; Post-traumatic epilepsy; Postural orthostatic tachycardia syndrome; Precerebral artery thrombosis; Pre-eclampsia; Preictal state; Premature labour; Premature menopause; Primary amyloidosis; Primary biliary cholangitis; Primary progressive multiple
sclerosis; Procedural shock; Proctitis herpes; Proctitis ulcerative; Product availability
issue; Product distribution issue; Product supply issue; Progressive facial
hemiatrophy; Progressive multifocal leukoencephalopathy; Progressive multiple
sclerosis; Progressive relapsing multiple sclerosis; Prosthetic cardiac valve
thrombosis; Pruritus; Pruritus allergic; Pseudovasculitis; Psoriasis; Psoriatic
arthropathy; Pulmonary amyloidosis; Pulmonary artery thrombosis; Pulmonary
embolism; Pulmonary fibrosis; Pulmonary haemorrhage; Pulmonary microemboli; Pulmonary oil microembolism; Pulmonary renal syndrome; Pulmonary sarcoidosis; Pulmonary sepsis; Pulmonary thrombosis; Pulmonary tumour thrombotic microangiopathy; Pulmonary vasculitis; Pulmonary veno-occlusive disease; Pulmonary venous thrombosis; Pyoderma gangrenosum; Pyostomatitis vegetans; Pyrexia; Quarantine; Radiation leukopenia; Radiculitis

Page 36
090177e196ea1800\Approved\Approved On: 30-A
pr-2021 09:26 (GMT)
FDA-CBER-2021-5683-0000089
BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL

brachial; Radiologically isolated syndrome; Rash; Rash erythematous; Rash pruritic; Rasmussen encephalitis; Raynaud’s phenomenon; Reactive capillary endothelial proliferation; Relapsing multiple sclerosis; Relapsing-remitting multiple sclerosis; Renal amyloidosis; Renal arteritis; Renal artery thrombosis; Renal embolism; Renal failure; Renal vascular thrombosis; Renal vasculitis; Renal vein embolism; Renal vein thrombosis; Respiratory arrest; Respiratory disorder; Respiratory distress; Respiratory failure; Respiratory paralysis; Respiratory syncytial virus bronchiolitis; Respiratory syncytial virus bronchitis; Retinal artery embolism; Retinal artery occlusion; Retinal artery thrombosis; Retinal
vascular thrombosis; Retinal vasculitis; Retinal vein occlusion; Retinal vein thrombosis; Retinol binding protein decreased; Retinopathy; Retrograde portal vein flow; Retroperitoneal fibrosis; Reversible airways obstruction; Reynold’s syndrome; Rheumatic brain disease; Rheumatic disorder; Rheumatoid arthritis; Rheumatoid factor increased; Rheumatoid factor positive; Rheumatoid factor quantitative increased; Rheumatoid lung; Rheumatoid neutrophilic dermatosis; Rheumatoid nodule; Rheumatoid nodule removal; Rheumatoid
scleritis; Rheumatoid vasculitis; Saccadic eye movement; SAPHO
syndrome; Sarcoidosis; SARS-CoV-1 test; SARS-CoV-1 test negative; SARS-CoV-1 test
positive; SARS-CoV-2 antibody test; SARS-CoV-2 antibody test negative; SARS-CoV-2
antibody test positive; SARS-CoV-2 carrier; SARS-CoV-2 sepsis; SARS-CoV-2 test; SARSCoV-2 test false negative; SARS-CoV-2 test false positive; SARS-CoV-2 test negative; SARSCoV-2 test positive; SARS-CoV-2 viraemia; Satoyoshi
syndrome; Schizencephaly; Scleritis; Sclerodactylia; Scleroderma; Scleroderma associated digital ulcer; Scleroderma renal crisis; Scleroderma-like reaction; Secondary amyloidosis; Secondary cerebellar degeneration; Secondary progressive multiple sclerosis; Segmented hyalinising vasculitis; Seizure; Seizure anoxic; Seizure cluster; Seizure like phenomena; Seizure prophylaxis; Sensation of foreign body; Septic embolus; Septic pulmonary embolism; Severe acute respiratory syndrome; Severe myoclonic epilepsy of infancy; Shock; Shock symptom; Shrinking lung syndrome; Shunt thrombosis; Silent thyroiditis; Simple partial seizures; Sjogren’s syndrome; Skin swelling; SLE arthritis; Smooth muscle antibody positive; Sneezing; Spinal artery embolism; Spinal artery thrombosis; Splenic
artery thrombosis; Splenic embolism; Splenic thrombosis; Splenic vein thrombosis; Spondylitis; Spondyloarthropathy; Spontaneous heparin-induced
thrombocytopenia syndrome; Status epilepticus; Stevens-Johnson syndrome; Stiff leg syndrome; Stiff person syndrome; Stillbirth; Still’s disease; Stoma site thrombosis; Stoma site vasculitis; Stress cardiomyopathy; Stridor; Subacute cutaneous lupus erythematosus; Subacute endocarditis; Subacute inflammatory demyelinating polyneuropathy; Subclavian artery embolism; Subclavian artery thrombosis; Subclavian vein thrombosis; Sudden unexplained death in epilepsy; Superior sagittal sinus thrombosis; Susac’s syndrome; Suspected COVID19; Swelling; Swelling face; Swelling of eyelid; Swollen tongue; Sympathetic
ophthalmia; Systemic lupus erythematosus; Systemic lupus erythematosus disease activity index abnormal; Systemic lupus erythematosus disease activity index decreased; Systemic lupus erythematosus disease activity index increased; Systemic lupus erythematosus rash; Systemic scleroderma; Systemic sclerosis
pulmonary; Tachycardia; Tachypnoea; Takayasu’s arteritis; Temporal lobe epilepsy; Terminal ileitis; Testicular autoimmunity; Throat tightness; Thromboangiitis
obliterans; Thrombocytopenia; Thrombocytopenic purpura; Thrombophlebitis; Thrombophlebitis migrans; Thrombophlebitis

Page 37
090177e196ea1800\Approved\Approved On: 30-A
pr-2021 09:26 (GMT)
FDA-CBER-2021-5683-0000090
BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL

neonatal; Thrombophlebitis septic; Thrombophlebitis superficial; Thromboplastin antibody positive; Thrombosis; Thrombosis corpora cavernosa; Thrombosis in device; Thrombosis mesenteric vessel; Thrombotic cerebral infarction; Thrombotic microangiopathy; Thrombotic stroke; Thrombotic thrombocytopenic purpura; Thyroid disorder; Thyroid stimulating immunoglobulin increased; Thyroiditis; Tongue amyloidosis; Tongue biting; Tongue oedema; Tonic clonic movements; Tonic convulsion; Tonic posturing; Topectomy; Total bile acids increased; Toxic epidermal necrolysis; Toxic leukoencephalopathy; Toxic oil syndrome; Tracheal obstruction; Tracheal oedema; Tracheobronchitis; Tracheobronchitis
mycoplasmal; Tracheobronchitis viral; Transaminases abnormal; Transaminases
increased; Transfusion-related alloimmune neutropenia; Transient epileptic
amnesia; Transverse sinus thrombosis; Trigeminal nerve paresis; Trigeminal
neuralgia; Trigeminal palsy; Truncus coeliacus thrombosis; Tuberous sclerosis
complex; Tubulointerstitial nephritis and uveitis syndrome; Tumefactive multiple
sclerosis; Tumour embolism; Tumour thrombosis; Type 1 diabetes mellitus; Type I
hypersensitivity; Type III immune complex mediated reaction; Uhthoff’s
phenomenon; Ulcerative keratitis; Ultrasound liver abnormal; Umbilical cord
thrombosis; Uncinate fits; Undifferentiated connective tissue disease; Upper airway
obstruction; Urine bilirubin increased; Urobilinogen urine decreased; Urobilinogen urine increased; Urticaria; Urticaria papular; Urticarial vasculitis; Uterine
rupture; Uveitis; Vaccination site thrombosis; Vaccination site vasculitis; Vagus nerve
paralysis; Varicella; Varicella keratitis; Varicella post vaccine; Varicella zoster
gastritis; Varicella zoster oesophagitis; Varicella zoster pneumonia; Varicella zoster
sepsis; Varicella zoster virus infection; Vasa praevia; Vascular graft thrombosis; Vascular pseudoaneurysm thrombosis; Vascular purpura; Vascular stent thrombosis; Vasculitic rash; Vasculitic ulcer; Vasculitis; Vasculitis gastrointestinal; Vasculitis necrotising; Vena cava embolism; Vena cava thrombosis; Venous intravasation; Venous recanalisation; Venous thrombosis; Venous thrombosis in pregnancy; Venous thrombosis limb; Venous thrombosis neonatal; Vertebral artery thrombosis; Vessel puncture site thrombosis; Visceral venous thrombosis; VIth nerve paralysis; VIth nerve paresis; Vitiligo; Vocal cord paralysis; Vocal cord
paresis; Vogt-Koyanagi-Harada disease; Warm type haemolytic anaemia; Wheezing; White nipple sign; XIth nerve paralysis; X-ray hepatobiliary abnormal; Young’s syndrome; Zika virus associated Guillain Barre syndrome

Posted in Health | Tagged , , , | Leave a comment

How to mirror multiple objects

I’m using Blender 3.1.0. This technique would work in Blender 2.8x+.

You might encounter situation that require mirroring multiple objects to save huge amount of time. How to do it?

I create three boxes: 1, 2, 3. To create mirrored boxes: 1′, 2′, 3′, do the following procedure.

Create an empty object named Empty.

Add mirror modifier on Box 1, and choose the Empty as Mirror Object.

Click Apply.

It would create mirrored Box 1′.

Select Box 2 and Box 3, then Box 1.

Press Crl+L. It opens up a pop-up menu.

Choose Copy modifiers

Box 1’s mirror modifier transfers to Box 2 and Box 3 and creates mirrored objects Box 2′, Box 3′.

Posted in Blender | Tagged , , , | Leave a comment

As the Wheels fall off the Plandemic Agenda the Globalists are now starting a War with Russia

https://brucecain.substack.com/p/as-the-wheels-fall-off-the-plandemic-4b8?s=r

Conclusions
I am a Perennial Hippie who believes in self sufficiency, inalienable rights and individualism — much like our founding fathers. The last thing I would want to see is a collectivist global system where everything is subject to the scrutiny of a global state. I’m also a pragmatist in the sense that I don’t want to foment a global nuclear war, which is where things seem headed.

I have said this many times: the greatest shortcoming of humanity is to underestimate the evil of our rulers. Our rulers want us enslaved through forced vaccines, vaccine passports and a digital currency. And it seems that, since the Plandemic has proven ineffective they have now decided to poke the bear: a bear that has enough nuclear arsenal to destroy the entire United States.

I recall, in the 1980’s, that anyone talking about a “New World Order” was called a conspiracy theorist. But then in 1991 President Bush embraced the idea of a “New World Order.” Then in 1992 Pelosi endorsed the UN’s Agenda21, which was the first template for instituting a “New World Order.” Globalist Corporate Media (CNN, MSNBC, FOX etc.) never mention this. More recently they refuse to acknowledge that Biden’s “Build Back Better” slogan is also the slogan of the World Economic Forum that is now pushing the “Great Reset” where ‘you will own nothing but be happy.”

I don’t want to live in a dystopian globalist nightmare where we all become nothing more than slaves on a Global Plantation. I don’t want that for my children or grandchildren. And if you feel as I do then it is time to peacefully rise up. Go to protests. Go before your City Council and School Boards. Demand that the entire litany of mandates — forced vaccination, vaccine passports, digital ID’s — are absolutely thrown out the window. People that were fired for not getting the mRNA injections should be reinstated. Our lives must carry on, just as they did before the staged Plandemic of 2020. Back to the old normal.

Wake up world. And remember . . .

All of us is all we need.
Bruce W. Cain

03/02/2022

Posted in Bigger reality | Tagged , , , , | Leave a comment